Aarti Pharmalabs Cash Flow Annual

BSE: 543748 | NSE: AARTIPHARM | ISIN: INE0LRU01027 | Sector: Biotechnology & Drugs

812.00 +22.70 (2.88%)Updated : 16 Sep 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Issuance( Retirement)of Debt Net	245.56	121.66	45.06	-124.29
Net Changein Cash	1.80	-16.90	11.51	-71.15
Cash Taxes Paid	46.93	64.53	56.94	62.38
Net Income/ Starting Line	227.72	360.69	300.49	260.77
Total Cash Dividends Paid	-36.26	-31.72	-18.13	-18.13
Changesin Working Capital	-153.89	-157.93	-181.83	-94.95
Cashfrom Operating Activities	261.93	330.14	216.35	250.12
Cash Interest Paid	38.73	24.51	17.21	21.05
Cashfrom Financing Activities	170.58	65.43	9.72	-163.46
Issuance( Retirement)of Stock Net	0.01	0.00	-	-
Depreciation/ Depletion	104.34	86.90	73.24	62.54
Other Investing Cash Flow Items Total	17.60	31.40	-15.78	-38.15
Capital Expenditures	-448.31	-443.88	-198.79	-119.66
period Type	-	-	-	-
Non- Cash Items	83.76	40.48	24.46	21.75
Financing Cash Flow Items	-38.73	-24.51	-17.21	-21.05
period Length	12.00	12.00	12.00	12.00
Cashfrom Investing Activities	-430.72	-412.48	-214.56	-157.80

*All figures in crores except per share values

272.00+6.05(2.27%)

1,260.00+20.50(1.65%)

11,053.00+157.00(1.44%)

1,196.80-29.75 (-2.43%)

185.95-2.60 (-1.38%)

Related News